Overview
Since 2005, Qpharma has offered medicinal products and medical preparations with a focus on quality and safety. Its portfolio covers otolaryngology, gynecology, urology, neurology, pediatrics and orthopedics, and is based on current medical knowledge.
Financials
Revenue history (in m)
Filing timeliness
Financial statements were filed on time, on average 47 days early. All were audited by a statutory auditor.
- 202524/03/2026
- 202402/07/2025
- 202304/07/2024
- 202226/06/2023
- 202107/07/2022
- 202018/06/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Trademarks
Qpharma holds 1 active trademark registered with the Polish Patent Office. 3 marks have expired or were not registered. The first mark was filed in 2006.
| Mark | Protected until | |
|---|---|---|
| Qpharma POMAGAMY LECZYĆ | Jun 13, 2034 | |
| Kiedy mózg potrzebuje specjalisty(word) | – | |
| Usłyszeć świat(word) | – | |
| Qpharma | – |
Authorized Representatives
Manner of representation
President of the Management Board independently, or two Vice-Presidents acting jointly.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Fundacja Rodzinna Czarny Dom w Organizacji | 100 | $13,506.21 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2007-11-27.
15 1240 6074 1789 0011 0350 2482
78 1600 1462 1085 8307 2000 0005- 42 1240 6074 1978 0011 0350 2440
Debt
No entries in the National Debtors Register (KRZ).
Public aid
7 public aid cases recorded, with a total value of $663,505.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 13, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $19,449$19,449 | Prezes Banku Gospodarstwa Krajowego | |
| Dec 19, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $22,551$22,551 | Prezes Banku Gospodarstwa Krajowego | |
| Aug 4, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $2,153$2,153 | Prezydent Miasta Stołecznego Warszawy |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Optifarmasp. z o.o. + limited partnership | $29,560,928.95 | optifarma.com | ||
| Bionorica Polskasp. z o.o. | $19,802,926.77 | bionorica.pl | ||
| Woerwag Pharma Polskasp. z o.o. | $16,858,061.27 | woerwagpharma.pl | ||
| Ursapharm Polandsp. z o.o. | $16,296,973.60 | ursapharm.pl | ||
| Vitamed Pharmaceuticalssp. z o.o. | $14,515,124.01 | vitamed.pl | ||
| Pharmabestsp. z o.o. | $13,942,252.57 | pharmabest.pl | ||
| PolypharmS.A. | $13,660,727.48 | polypharm.pl | ||
| Interpharmasp. z o.o. | $12,321,125.25 | interpharma.com.pl | ||
| MassmedicaS.A. | $8,216,274.00 | massmedica.com | ||
| Pharm Supplysp. z o.o. | $6,901,751.00 | pharmsupply.com.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-04-24 | Switch to PKD 2025 (5 PKD 2007 codes → 5 PKD 2025 codes) | |
| 2018-07-13 | Switch to PKD 2007 (17 PKD 2004 codes → 10 PKD 2007 codes) | |
| 2007-11-13 | Entered in the register |
FAQ
Last updated: 2026-10-07